GDRX Stock Analysis: Buy, Sell, or Hold?
GDRX - GoodRx Holdings, Inc. Class A Common Stock
$2.67
0.10 (3.89%)
▲
5d:
-2.2%
30d:
+4.3%
90d:
+28.37%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When GDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GDRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: GDRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.62
Based on 10.0% avg growth
INTRINSIC VALUE TODAY
$2.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GDRX is currently trading at $2.67, which is considered slightly low relative to its 30-day fair value range of $2.53 to $2.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.5) compared to its historical average (6.3). At these levels, the market is pricing in 5.8% annual earnings growth.
Technical Outlook: Technically, GDRX is in a uptrend. Immediate support is located at $2.48, while resistance sits at $2.77. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.18 (+19.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GDRX is in a uptrend. Immediate support is located at $2.48, while resistance sits at $2.77. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.18 (+19.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.53 -
$2.86
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading below Wall St target ($3.18)
- BULLISH: Expecting earnings turnaround to 5.8% growth with -4.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$2.53 -
$2.86
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.48
Resistance Level
$2.78
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.45
Wall Street Target
$3.18
(+19.1%)
Revenue Growth (YoY)
-4.4%
Earnings Growth (YoY)
-88.3%
Profit Margin
2.6%
Valuation Premium vs History
+5.8% premium
PE vs Historical
7.5 vs 6.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.8%
(market-implied from PE analysis)
1-Year Target
$2.82
(+6%)
2-Year Target
$2.99
(+12%)
3-Year Target
$3.16
(+18%)
3-Yr Target (if PE normalizes)
(PE: 7→6)
PE COMPRESSION
$2.67
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 16.0%)
$12.18
(+356%)
Base:
(SPY PE: 7.5, Growth: 16.0%)
$4.17
(+56%)
Bear:
(PE: 6.3, Growth: 16.0%)
$3.52
(+32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 42.83 | Current EPS (TTM): $0.06
Bull Case
$5.65
(+112%)
Analyst growth 100.0%, PE expands to 47.1
Base Case
$5.14
(+93%)
Market implied 100.0%, PE stable at 42.8
Bear Case
$1.75
(-35%)
Severe decline -20.0%, PE contracts to 36.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 6:28 PM ET
Data refreshes hourly during market hours. Next update: 7:28 PM
Data refreshes hourly during market hours. Next update: 7:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 51 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 53 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 56 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 57 HOLD |
Advanced GDRX Option Strategies
Professional options setups generated by AI based on today's GDRX price and gamma walls.
